Trump will sign three executive orders on lowering drug prices: chief of staff

10 July 2020 - President Donald Trump will sign three executive orders on lowering prescription drug prices, White House Chief ...

Read more →

How can cancer drug prices better match their benefits? Germany offers a cost-saving model

10 July 2020 - After Germany revamped its approach to purchasing medicines a decade ago, the prices negotiated by the ...

Read more →

Despite the pandemic, prices for many drugs keep rising

9 July 2020 - Despite the economic hardships the COVID-19 pandemic has created for many Americans, drug makers raised list ...

Read more →

Drug prices steadily rise amid pandemic, data shows

7 July 2020 - Some drugmakers have delayed or staggered increases amid increased scrutiny and the fear of catching President Donald ...

Read more →

Did a pharma trade group try to sabotage a Dutch government report on compulsory licensing?

7 July 2020 - Dutch government commission on compulsory licensing was nearly sabotaged last month after one of its members ...

Read more →

Lessons from the impact of price regulation on the pricing of anti-cancer drugs in Germany

7 July 2020 - Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly ...

Read more →

Unsustainable low prices causing generic drug market failure leading to supply chain disruptions and shortages

6 July 2020 - Ongoing disruptions in the globalised pharma supply chains causing drug shortages in the United States are ...

Read more →

Mylan prices its generic remdesivir in India at $64 per 100 mg vial

6 July 2020 - Mylan will launch a generic version of Gilead Sciences’ COVID-19 anti-viral remdesivir in India at 4,800 rupees, ...

Read more →

CMS’s proposed Medicaid best price loophole for value based purchasing of drugs

6 July 2020 - For three decades, US pharmaceutical companies have agreed to sell their products to Medicaid programs at ...

Read more →

Will we be hostages to drug makers’ Covid vaccine pricing?

6 July 2020 - The United States is the only developed nation unable to balance cost, efficacy and social good in ...

Read more →

$600 or $3,120? Gilead puts a price tag on COVID-19 relief

2 July 2020 - The pharmaceutical industry has been stubbornly opaque about how much it truly spends on research and development. ...

Read more →

ICER publishes white paper on alternative policies for drug and vaccine pricing during a pandemic, announces cross-stakeholder discussion series

2 July 2020 - The Institute for Clinical and Economic Review today published a white paper to inform public and policy ...

Read more →

Some U.S. government contracts for COVID-19 research could skirt affordable pricing laws

1 July 2020 - A new report finds that the U.S. government awarded several drug makers contracts for coronavirus research ...

Read more →

Companies have raised prices on 245 drugs during pandemic, advocacy group says

29 June 2020 - Pharmaceutical companies have raised prices on 245 drugs since the first U.S. coronavirus case was reported ...

Read more →

Canada federal court dismisses drug makers' plea challenging drug price rules

30 June 2020 - The federal court of Canada on Monday dismissed a plea by drug makers challenging the Canadian ...

Read more →